NICE no for Celgene's Vidaza violates Human Rights Act, say patient groups
23 March 2010
Francesca Bruce
UK patient groups have lodged an appeal against health technology appraisal body
NICE's decision to decline Celgene's anticancer, Vidaza (5-azacitidine), for patients with myelodysplastic syndromes (MDS). The patient groups say the recommendations are "incompatible" with the UK's 1998 Human Rights...
Please Login to read the full article.
23 March 2010
Francesca Bruce
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
